Related Experiment Video
Updated: May 23, 2025

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Ketamine: An emerging agent in the management of neuropsychiatric disorders
Nathan Menke1, Elizabeth Hoffman1, Kelsey Gaylor1
1Department of Psychiatry, Michigan Medicine, University of Michigan, United States.
Abstract:
Ketamine's unique pharmacological profile, safety, modulation of multiple neurotransmitter systems, and ability to produce neuroplastic changes make it a subject of study with implications for a wide range of neuropsychiatric disorders beyond its traditional use as an anesthetic agent. This article aims to provide an overview of the pharmacology of ketamine and briefly discuss its emerging use in treating: substance use disorders (alcohol, cannabis, cocaine, and opioids); withdrawal syndromes (opioid and alcohol); acute and chronic pain syndromes; and severe psychomotor agitation. Ketamine for the treatment of depression and suicidality is well established; however, the focus of this paper is to outline less common indications.
More Related Videos
10:32A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons
Published on: November 7, 2014
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy